Allarity Therapeutics Stock Analysis

Allarity Stock Analysis Notes

About 12.0% of the company shares are held by company insiders. The company has price-to-book (P/B) ratio of 0.43. Some equities with similar Price to Book (P/B) outperform the market in the long run. Allarity Therapeutics recorded a loss per share of 10.98. The entity had not issued any dividends in recent years. The firm had 1:30 split on the 11th of September 2024. Allarity Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing oncology therapeutics using drug-specific companion diagnostics generated by its drug response predictor technology. The company was incorporated in 2004 and is headquartered in Cambridge, Massachusetts. Allarity Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 13 people. For more info on Allarity Therapeutics please contact James JD at 401 426 4664 or go to https://www.allarity.com.

Allarity Therapeutics Investment Alerts

Allarity Therapeutics Upcoming and Recent Events

Allarity Largest EPS Surprises

View All Earnings Estimates

Allarity Stock Institutional Investors

Note, although Allarity Therapeutics' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Allarity Market Capitalization

The company currently falls under 'Nano-Cap' category with a current market capitalization of 2.06 M.

Allarity Profitablity

Management Efficiency

Allarity Therapeutics has return on total asset (ROA) of (0.4772) % which means that it has lost $0.4772 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.2182) %, meaning that it created substantial loss on money invested by shareholders. Allarity Therapeutics' management efficiency ratios could be used to measure how well Allarity Therapeutics manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Allarity Therapeutics' Return On Capital Employed is relatively stable compared to the past year. As of 11/25/2024, Return On Equity is likely to grow to 4.54, while Return On Tangible Assets are likely to drop (6.28). At this time, Allarity Therapeutics' Total Assets are relatively stable compared to the past year. As of 11/25/2024, Non Current Assets Total is likely to grow to about 17.3 M, while Total Current Assets are likely to drop slightly above 1.9 M.

Technical Drivers

As of the 25th of November, Allarity Therapeutics shows the Risk Adjusted Performance of (0.18), standard deviation of 7.42, and Mean Deviation of 5.02. Allarity Therapeutics technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Please confirm Allarity Therapeutics standard deviation and value at risk to decide if Allarity Therapeutics is priced correctly, providing market reflects its regular price of 1.27 per share. Given that Allarity Therapeutics is a hitting penny stock territory we recommend to closely look at its jensen alpha.

Allarity Therapeutics Price Movement Analysis

Allarity Therapeutics Insider Trading Activities

Allarity Therapeutics Outstanding Bonds

Allarity Therapeutics Predictive Daily Indicators

Allarity Therapeutics Forecast Models

Allarity Therapeutics' time-series forecasting models are one of many Allarity Therapeutics' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Allarity Therapeutics' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Allarity Therapeutics prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Allarity shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Allarity Therapeutics. By using and applying Allarity Stock analysis, traders can create a robust methodology for identifying Allarity entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Allarity analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Allarity analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Allarity Therapeutics stock analysis indicators help investors evaluate how Allarity Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Allarity Therapeutics shares will generate the highest return on investment. By understating and applying Allarity Therapeutics stock analysis, traders can identify Allarity Therapeutics position entry and exit signals to maximize returns.

When running Allarity Therapeutics' price analysis, check to measure Allarity Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Allarity Therapeutics is operating at the current time. Most of Allarity Therapeutics' value examination focuses on studying past and present price action to predict the probability of Allarity Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Allarity Therapeutics' price. Additionally, you may evaluate how the addition of Allarity Therapeutics to your portfolios can decrease your overall portfolio volatility.